Matthew Kuhn

Matthew Kuhn is Founder & CEO of Taurus Vascular, a Houston-based medical device company focused on improving long-term outcomes for patients with aortic aneurysms. Taurus Vascular is developing a safe, effective, and easy-to-use medical device to reduce the risk and impact of endoleaks after endovascular aortic aneurysm repair (EVAR).

Matthew Kuhn is a Founder-in-Residence at Texas Medical Center Innovation, where he is creating solutions for healthcare’s greatest unmet needs via the TMCi Biodesign Program.

Matthew was previously a Project Leader and Design Engineer at the Johnson & Johnson Center for Device Innovation. In this role, Matthew was responsible for leading all aspects of accelerated medical device development for several new innovative technologies.

Matthew's responsibilities included creating new concepts, hands-on prototyping and fabrication, preclinical testing, patent protection, product development, multidisciplinary team leadership, and project management.

Matthew graduated from the University of Delaware with a B.S. in Biomedical Engineering and received a Master's in Bioengineering at Rice University. He is an inventor on more than 40 US and international pending patents, covering a diverse range of clinical specialties including surgical oncology, laparoscopic surgery, and cardiovascular electrophysiology.